6 Recommendations for further research

6 Recommendations for further research

6.1 A trial comparing 37.5 mg sunitinib with 800 mg imatinib is currently recruiting participants.

6.2 The Committee considered that rigorous data collection is needed on the life-extending benefits of sunitinib.

  • National Institute for Health and Care Excellence (NICE)